Company Number: 15075074

Analysis Date: 2025-07-29 12:32 UTC

1. Industry Classification
   LP SD ONE HUNDRED FIVE LIMITED operates within SIC code 47730, which covers "Dispensing chemist in specialised stores." This sector is a niche within the broader retail pharmacy industry, characterized by the dispensing of prescription medicines alongside specialised healthcare products. Key industry characteristics include regulatory oversight by the Medicines and Healthcare products Regulatory Agency (MHRA), dependency on NHS contracts, and a customer base requiring personalised pharmaceutical care. The sector involves complex supply chain management, strict compliance with pharmaceutical legislation, and competitive pressures from both large pharmacy chains and independent chemists.

2. Relative Performance
   As a newly incorporated private limited company (incorporated August 2023), LP SD ONE HUNDRED FIVE LIMITED has reported modest financials for its first accounting period ending September 2024. The company shows net current assets of £10,884 and net assets of the same amount, with a very low level of cash (£2) but significant trade debtors (£46,624) and other debtors (£74,407). Shareholders’ funds stand at £10,884, reflecting minimal equity capital (£1 share capital) and accumulated profits. The filing status is compliant, and the company qualifies for the small companies regime exemption from audit. Compared to industry norms, where established pharmacy businesses typically display higher turnover, cash reserves, and more substantial tangible assets, this company is operating on a micro or small scale, indicative of an early-stage or niche operation. The average employee count of 5 also suggests a small operational footprint relative to larger chains that employ hundreds or thousands.

3. Sector Trends Impact
   The specialised dispensing chemist sector is currently influenced by several trends:

• Increasing demand for personalised and specialised pharmaceutical services, driven by an aging population and chronic disease prevalence.
• Regulatory changes impacting reimbursement rates and pharmacy funding through NHS contracts, which can pressure margins.
• Growing competition from online pharmacies and large retail chains offering convenience and discounts.
• Technological integration, including digital prescription services and patient management systems, enhancing operational efficiency and customer engagement.
• Supply chain challenges and inflationary pressures on pharmaceutical products and operating costs.
  LP SD ONE HUNDRED FIVE LIMITED’s nascent status means it may still be positioning itself to leverage these trends, particularly by focusing on specialised dispensing services that distinguish it from general retailers and online competitors.

4. Competitive Positioning
   The company appears to be a niche player within the specialised chemist segment, possibly established as a subsidiary or controlled entity of larger groups (Lloyds Pharmacy Limited and SNJ Health Limited hold significant control). This relationship likely provides strategic advantages such as supply chain access, regulatory compliance support, and established customer channels. However, the company’s financials reflect the typical profile of a startup or newly formed entity: low capitalisation, minimal tangible assets, and a workforce size consistent with a focused, possibly single-location operation. While it may currently lack the scale and cash reserves of industry leaders like Lloyds Pharmacy or Boots UK, its backing by established parent companies positions it well for growth. Its strengths include potential integration within a larger corporate network and specialised focus, while weaknesses include limited financial resources and operational scale, which may constrain rapid expansion or investment in technology and marketing.